Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol

被引：0
|
作者：
Matthias Uhl
Lutz Edler
Alexandra D Jensen
Gregor Habl
Jan Oelmann
Falk Röder
Oliver Jäckel
Jürgen Debus
Klaus Herfarth
机构：
[1] University of Heidelberg,Department of Radiation Oncology
[2] Heidelberg Ion Therapy Center (HIT),undefined
[3] German Cancer Research Center (dkfz),undefined
来源：
Radiation Oncology | / 9卷
关键词：
Sacral chordoma; Chordoma; Carbon ion therapy; Proton therapy; Irradiation; Randomized trial; Hypofractionation; Heavy ion therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol
    Uhl, Matthias
    Edler, Lutz
    Jensen, Alexandra D.
    Habl, Gregor
    Oelmann, Jan
    Roeder, Falk
    Jakel, Oliver
    Debus, Juergen
    Herfarth, Klaus
    RADIATION ONCOLOGY, 2014, 9
  • [2] Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC): An open label, randomized, stratified phase II trial
    Seidensaal, Katharina
    Froehlke, Andreas
    Lentz-Hommertgen, Adriane
    Lehner, Burkhard
    Geisbuesch, Andreas
    Meis, Jan
    Liermann, Jakob
    Kudak, Andreas
    Stein, Katharina
    Uhl, Matthias
    Tessonnier, Thomas
    Mairani, Andrea
    Debus, Juergen
    Herfarth, Klaus
    RADIOTHERAPY AND ONCOLOGY, 2024, 198
  • [3] Phase II randomized trial of conventional versus hypofractionated post-mastectomy proton radiotherapy
    Mutter, Robert
    Giri, Sharmila
    Fruth, Briant
    Remmes, Nicholas
    Anand, Aman
    Ruddy, Kathryn
    Villarraga, Hector
    Patarroyo, Sebastian Santos
    Yan, Elizabeth
    Merrell, Kenneth
    Mcgee, Lisa
    Vern-Gross, Tamara
    Stish, Bradley
    Gao, Robert
    Boughey, Judy C.
    Park, Sean
    Corbin, Kimberly
    Vargas, Carlos
    CANCER RESEARCH, 2023, 83 (05)
  • [4] Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial
    Pedretti, Sara
    Masini, Laura
    Turco, Enrico
    Triggiani, Luca
    Krengli, Marco
    Meduri, Bruno
    Pirtoli, Luigi
    Borghetti, Paolo
    Pegurri, Ludovica
    Riva, Nada
    Gatta, Roberto
    Fusco, Vincenzo
    Scoccianti, Silvia
    Bruni, Alessio
    Ricardi, Umberto
    Santoni, Riccardo
    Magrini, Stefano M.
    Buglione, Michela
    JOURNAL OF NEURO-ONCOLOGY, 2019, 143 (03) : 447 - 455
  • [5] Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial
    Sara Pedretti
    Laura Masini
    Enrico Turco
    Luca Triggiani
    Marco Krengli
    Bruno Meduri
    Luigi Pirtoli
    Paolo Borghetti
    Ludovica Pegurri
    Nada Riva
    Roberto Gatta
    Vincenzo Fusco
    Silvia Scoccianti
    Alessio Bruni
    Umberto Ricardi
    Riccardo Santoni
    Stefano M. Magrini
    Michela Buglione
    Journal of Neuro-Oncology, 2019, 143 : 447 - 455
  • [6] Multicentric randomized phase II trial of gamma knife surgery (GKS) versus image-guided, intensity modulated radiation therapy (IG-IMRT) in patients with sacrococcygeal chordoma.
    Lu, Shun
    Lang, Jin Yi
    Wang, Weidong
    Feng, Mei
    Zou, Bingwen
    Peng, Xinhao
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] HYPCON trial: A phase II randomized study evaluating hypofractionated versus conventional adjuvant radiation therapy in head and neck malignancies.
    Ghosh, Adrija
    Dagar, Abhilash
    Izzuddeen, Yousra
    Vivekanandan, Abiramasundari
    Raj, Jaswin
    Hazarika, Sangeeta
    Nair, Ambily
    Panda, Smriti
    Sharma, Jyoti
    Singhal, Abhinav
    Das, Kalpa
    Bhasker, Suman
    Thakar, Alok
    Mallick, Supriya
    Sharma, Daya Nand
    Sharma, Aman
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 143 - 143
  • [8] A Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer
    Ritter, M. A.
    Forman, J. D.
    Kupelian, P. A.
    Petereit, D. G.
    Lawton, C. A.
    Chappell, R. J.
    Tome, W. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S80 - S81
  • [9] Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trial
    Yeoh, Eric E.
    Holloway, Richard H.
    Fraser, Robert J.
    Botten, Rochelle J.
    Di Matteo, Addolorata C.
    Butters, Julie
    Weerasinghe, Sujeeva
    Abeysinghe, Prasad
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (04): : 1072 - 1083
  • [10] Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study
    Anna V Nikoghosyan
    Irini Karapanagiotou-Schenkel
    Marc W Münter
    Alexandra D Jensen
    Stephanie E Combs
    Jürgen Debus
    BMC Cancer, 10
12345